process for the production of polisaccardi for extraction from microbial bodies of haemophilus influence and the product obtained and pharmaceutical compositions containing it as an ingredient (or

摘要

Novel polysaccharide extracts of microbial bodies of Haemophilus influenza having an apparent molecular weight greater than 200,000 and constituted principally of galactose, glucose and mannose having remarkable antigenic and immunostimulating activity with very good tolerance in warm-blooded animals and a process for their preparation.